← Leaderboards
Peter A Jones
Van Andel Research Institute
$57,981,446
Attributed
$59,886,802
Total exposure
35
Grants
31
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.6M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$154,202,054 · 38
By mechanism
P30$105,728,942 · 27
R01$12,278,344 · 3
P50$11,903,446 · 1
R35$10,890,656 · 2
P01$6,799,342 · 2
T32$4,401,060 · 2
Top collaborators
- Stephen B Baylin9 shared
- Jean-Pierre J Issa5 shared
- Peter W Laird4 shared
- Gangning Liang2 shared
Most similar at Van Andel Research Institute
Same institution · by research overlap
- Gerd P Pfeifer$23,178,447
- Peter W Laird$31,903,324
Others in their field
Top investigators on “Usc/Norris Comprehensive Cancer Center And Hospital”
- Stephen B Gruber · University Of Michigan At Ann Arbor$7,227,752
- Caryn Lerman · University Of Southern California$5,108,794
- Susan G. Groshen · Children'S Hospital Los Angeles$3,820,718
- David Ian Quinn · University Of Southern California$3,704,864
- Heinz Josef Lenz · University Of Southern California$2,863,875
- Anthony Boutros El-Khoueiry · University Of Southern California$2,258,846
Research focus
Usc/Norris Comprehensive Cancer Center And HospitalMalignant NeoplasmsResearch PersonnelCancer CenterFundingEpigenetic ProcessComprehensive Cancer CenterAnticancer ResearchMemberProgramsResource SharingGrantDna MethylationTranslational ResearchClinical ResearchCancer Center Support GrantTumorBaseResourcesCellsLeadershipDesignClinical TrialsResearch Study
Grant awards (200)
Epigenetic Therapies - New Approaches$2,521,916
P50 · FY2025 · CA
Establishing and Interpreting Abnormal DNA Methylation in Cancer$1,022,083
R35 · FY2025 · CA · contact PI
Cancer Epigenetics Training (CET) Program$494,901
T32 · FY2025 · CA · contact PI
Epigenetic Therapies - New Approaches$2,421,039
P50 · FY2024 · CA
Establishing and Interpreting Abnormal DNA Methylation in Cancer$1,065,709
R35 · FY2024 · CA · contact PI
Cancer Epigenetics Training (CET) Program$477,477
T32 · FY2024 · CA · contact PI
Epigenetic Therapies - New Approaches$2,345,381
P50 · FY2023 · CA
Establishing and Interpreting Abnormal DNA Methylation in Cancer$1,146,514
R35 · FY2023 · CA · contact PI
Targeting DNA Methylation and the Cancer Epigenome$1,094,991
R35 · FY2023 · CA · contact PI
Cancer Epigenetics Training (CET) Program$470,412
T32 · FY2023 · CA · contact PI
Epigenetic Therapies - New Approaches$2,345,381
P50 · FY2022 · CA
Targeting DNA Methylation and the Cancer Epigenome$1,094,991
R35 · FY2022 · CA · contact PI
Cancer Epigenetics Training (CET) Program$306,520
T32 · FY2022 · CA · contact PI
Epigenetic Therapies - New Approaches$2,269,729
P50 · FY2021 · CA
Targeting DNA Methylation and the Cancer Epigenome$1,117,337
R35 · FY2021 · CA · contact PI
Cancer Epigenetics Training (CET) Program$143,878
T32 · FY2021 · CA · contact PI
Targeting DNA Methylation and the Cancer Epigenome$1,117,337
R35 · FY2020 · CA · contact PI
Targeting DNA Methylation and the Cancer Epigenome$853,180
R35 · FY2019 · CA · contact PI
Targeting DNA Methylation and the Cancer Epigenome$1,117,337
R35 · FY2018 · CA · contact PI
Targeting DNA Methylation and the Cancer Epigenome$1,139,837
R35 · FY2017 · CA · contact PI
Mechanisms of De Novo Methylation in Cancer$502,899
R01 · FY2016 · CA · contact PI
Biostatistics Core$755,906
P30 · FY2015 · CA · contact PI
Epigenetic Drivers of Cancer (PQ 10)$698,103
R01 · FY2015 · CA
Molecular Genomics Core$657,769
P30 · FY2015 · CA · contact PI
Administrative Core$652,330
P30 · FY2015 · CA · contact PI
Translational Pathology Core$636,643
P30 · FY2015 · CA · contact PI
Mechanisms of De Novo Methylation in Cancer$502,899
R01 · FY2015 · CA · contact PI
Developmental Funds$462,458
P30 · FY2015 · CA · contact PI
Senior Leadership$441,652
P30 · FY2015 · CA · contact PI
Clinical Investigations$407,532
P30 · FY2015 · CA · contact PI
Leaders of Scientific Research Programs$390,547
P30 · FY2015 · CA · contact PI
Molecular and Cell Biology Core$292,312
P30 · FY2015 · CA · contact PI
Protocol Specific Research Support$241,520
P30 · FY2015 · CA · contact PI
Protocol Review and Monitoring System$180,270
P30 · FY2015 · CA · contact PI
Cell and Tissue Imaging Core$177,598
P30 · FY2015 · CA · contact PI
Data And Safety Monitoring$169,621
P30 · FY2015 · CA · contact PI
Cancer Research Informatics Core$157,091
P30 · FY2015 · CA · contact PI
Bioreagent and Cell Culture Core$146,247
P30 · FY2015 · CA · contact PI
Transgenic and Knockout Mouse core$143,520
P30 · FY2015 · CA · contact PI
Small Animal Imaging Core$121,100
P30 · FY2015 · CA · contact PI
Flow Cytometry Core$102,723
P30 · FY2015 · CA · contact PI
Program Planning$94,339
P30 · FY2015 · CA · contact PI
Biostatistics Core$756,209
P30 · FY2014 · CA · contact PI
Administrative Core$645,664
P30 · FY2014 · CA · contact PI
Translational Pathology Core$631,729
P30 · FY2014 · CA · contact PI
Epigenetic Drivers of Cancer (PQ 10)$571,757
R01 · FY2014 · CA
Mechanisms of De Novo Methylation in Cancer$525,399
R01 · FY2014 · CA · contact PI
Developmental Funds$457,709
P30 · FY2014 · CA · contact PI
Senior Leadership$435,694
P30 · FY2014 · CA · contact PI
Clinical Investigations$392,416
P30 · FY2014 · CA · contact PI
Leaders of Scientific Research Programs$380,239
P30 · FY2014 · CA · contact PI
Molecular Genomics Core$371,387
P30 · FY2014 · CA · contact PI
De Novo DNA Methylation in Bladder Cancer$284,702
R01 · FY2014 · CA
Molecular and Cell Biology Core$272,255
P30 · FY2014 · CA · contact PI
Protocol Specific Research Support$219,582
P30 · FY2014 · CA · contact PI
Protocol Review and Monitoring System$156,053
P30 · FY2014 · CA · contact PI
Cell and Tissue Imaging Core$153,282
P30 · FY2014 · CA · contact PI
Data And Safety Monitoring$143,994
P30 · FY2014 · CA · contact PI
Cancer Research Informatics Core$132,012
P30 · FY2014 · CA · contact PI
Bioreagent and Cell Culture Core$130,252
P30 · FY2014 · CA · contact PI
Transgenic and Knockout Mouse core$117,937
P30 · FY2014 · CA · contact PI
Small Animal Imaging Core$94,176
P30 · FY2014 · CA · contact PI
Flow Cytometry Core$75,615
P30 · FY2014 · CA · contact PI
Program Planning$66,924
P30 · FY2014 · CA · contact PI
Biostatistics Core$749,167
P30 · FY2013 · CA · contact PI
Molecular Genomics Core$644,305
P30 · FY2013 · CA · contact PI
Administrative Core$638,721
P30 · FY2013 · CA · contact PI
Translational Pathology Core$627,284
P30 · FY2013 · CA · contact PI
Epigenetic Drivers of Cancer (PQ 10)$553,214
R01 · FY2013 · CA
Developmental Funds$461,844
P30 · FY2013 · CA · contact PI
Senior Leadership$439,630
P30 · FY2013 · CA · contact PI
Mechanisms of De Novo Methylation in Cancer$411,192
R37 · FY2013 · CA · contact PI
Clinical Investigations$388,844
P30 · FY2013 · CA · contact PI
Leaders of Scientific Research Programs$382,029
P30 · FY2013 · CA · contact PI
De Novo DNA Methylation in Bladder Cancer$275,896
R01 · FY2013 · CA
Molecular and Cell Biology Core$269,330
P30 · FY2013 · CA · contact PI
Protocol Specific Research Support$217,218
P30 · FY2013 · CA · contact PI
Protocol Review and Monitoring System$154,373
P30 · FY2013 · CA · contact PI
Cell and Tissue Imaging Core$151,632
P30 · FY2013 · CA · contact PI
Data And Safety Monitoring$141,457
P30 · FY2013 · CA · contact PI
Cancer Research Informatics Core$130,590
P30 · FY2013 · CA · contact PI
Bioreagent and Cell Culture Core$123,458
P30 · FY2013 · CA · contact PI
Transgenic and Knockout Mouse core$116,666
P30 · FY2013 · CA · contact PI
Small Animal Imaging Core$92,671
P30 · FY2013 · CA · contact PI
Flow Cytometry Core$74,803
P30 · FY2013 · CA · contact PI
Program Planning$66,207
P30 · FY2013 · CA · contact PI
Senior Leadership$12,500
P30 · FY2013 · CA · contact PI
Senior Leadership$12,459
P30 · FY2013 · CA · contact PI
Biostatistics Core$799,313
P30 · FY2012 · CA · contact PI
Molecular Genomics Core$686,940
P30 · FY2012 · CA · contact PI
Administrative Core$680,984
P30 · FY2012 · CA · contact PI
Translational Pathology Core$671,352
P30 · FY2012 · CA · contact PI
Epigenetic Drivers of Cancer (PQ 10)$614,511
R01 · FY2012 · CA
Developmental Funds$502,248
P30 · FY2012 · CA · contact PI
Senior Leadership$478,092
P30 · FY2012 · CA · contact PI
Mechanisms of De Novo Methylation in Cancer$439,342
R37 · FY2012 · CA · contact PI
Clinical Investigations$415,289
P30 · FY2012 · CA · contact PI
Leaders of Scientific Research Programs$412,880
P30 · FY2012 · CA · contact PI
De Novo DNA Methylation in Bladder Cancer$293,507
R01 · FY2012 · CA · contact PI
Molecular and Cell Biology Core$287,148
P30 · FY2012 · CA · contact PI
TRAINING GRANT IN VIRAL AND CHEMICAL CARCINOGENESIS$269,591
T32 · FY2012 · CA · contact PI
Protocol Specific Research Support$231,595
P30 · FY2012 · CA · contact PI
Protocol Review and Monitoring System$164,590
P30 · FY2012 · CA · contact PI
Cell and Tissue Imaging Core$161,670
P30 · FY2012 · CA · contact PI
Data And Safety Monitoring$149,786
P30 · FY2012 · CA · contact PI
Cancer Research Informatics Core$139,234
P30 · FY2012 · CA · contact PI
Bioreagent and Cell Culture Core$131,594
P30 · FY2012 · CA · contact PI
Transgenic and Knockout Mouse core$124,389
P30 · FY2012 · CA · contact PI
Small Animal Imaging Core$98,289
P30 · FY2012 · CA · contact PI
Flow Cytometry Core$79,751
P30 · FY2012 · CA · contact PI
Program Planning$70,582
P30 · FY2012 · CA · contact PI
USC Norris Comprehensive Cancer Center (CORE) Support$6,160,984
P30 · FY2011 · CA · contact PI
Mechanisms of De Novo Methylation in Cancer$441,298
R37 · FY2011 · CA · contact PI
De Novo DNA Methylation in Bladder Cancer$293,507
R01 · FY2011 · CA · contact PI
TRAINING GRANT IN VIRAL AND CHEMICAL CARCINOGENESIS$284,136
T32 · FY2011 · CA · contact PI
USC Norris Comprehensive Cancer Center (CORE) Support$244,500
P30 · FY2011 · CA · contact PI
USC Norris Comprehensive Cancer Center (CORE) Support$74,923
P30 · FY2011 · CA · contact PI
USC Norris Comprehensive Cancer Center (CORE) Support$50,000
P30 · FY2011 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$6,464,088
P30 · FY2010 · CA · contact PI
Cancer Center Administration$942,425
P30 · FY2010 · CA · contact PI
Mechanisms of De Novo Methylation in Cancer$457,488
R37 · FY2010 · CA · contact PI
De Novo DNA Methylation in Bladder Cancer$302,584
R01 · FY2010 · CA · contact PI
TRAINING GRANT IN VIRAL AND CHEMICAL CARCINOGENESIS$277,222
T32 · FY2010 · CA · contact PI
Protocol Specific Research$177,144
P30 · FY2010 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$99,949
P30 · FY2010 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$98,980
P30 · FY2010 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$73,975
P30 · FY2010 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$6,658,653
P30 · FY2009 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$1,182,020
P30 · FY2009 · CA · contact PI
Cancer Center Administration$955,852
P30 · FY2009 · CA · contact PI
Mechanisms of De Novo Methylation in Cancer$450,944
R37 · FY2009 · CA · contact PI
DE NOVO DNA METHYLATION IN BLADDER CANCER$295,584
R01 · FY2009 · CA · contact PI
TRAINING GRANT IN VIRAL AND CHEMICAL CARCINOGENESIS$269,410
T32 · FY2009 · CA · contact PI
Protocol Specific Research$179,650
P30 · FY2009 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$100,000
P30 · FY2009 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$74,165
P30 · FY2009 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$49,863
P30 · FY2009 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$6,658,653
P30 · FY2008 · CA · contact PI
Cancer Center Administration$818,343
P30 · FY2008 · CA · contact PI
MECHANISMS OF DE NOVO METHYLATION IN CANCER$429,472
R01 · FY2008 · CA · contact PI
DE NOVO DNA METHYLATION IN BLADDER CANCER$295,584
R01 · FY2008 · CA · contact PI
TRAINING GRANT IN VIRAL AND CHEMICAL CARCINOGENESIS$241,247
T32 · FY2008 · CA · contact PI
Protocol Specific Research$153,835
P30 · FY2008 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$74,165
P30 · FY2008 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$6,578,401
P30 · FY2007 · CA · contact PI
Cancer Center Administration$920,230
P30 · FY2007 · CA · contact PI
MECHANISMS OF DE NOVO METHYLATION IN CANCER$426,956
R01 · FY2007 · CA · contact PI
DE NOVO DNA METHYLATION IN BLADDER CANCER$295,584
R01 · FY2007 · CA · contact PI
TRAINING PROGRAM IN VIRAL AND CHEMICAL CARCINOGENESIS$230,999
T32 · FY2007 · CA · contact PI
Protocol Specific Research$172,973
P30 · FY2007 · CA · contact PI
DE NOVO DNA METHYLATION IN BLADDER CANCER$49,536
R01 · FY2007 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$6,024,874
P30 · FY2006 · CA · contact PI
MOLECULAR MECHANISMS OF HUMAN BLADDER CARCINOGENESIS$1,400,378
P01 · FY2006 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$750,000
P30 · FY2006 · CA · contact PI
MECHANISMS OF DE NOVO METHYLATION IN CANCER$428,684
R01 · FY2006 · CA · contact PI
Cancer Center Administration$415,113
P30 · FY2006 · CA · contact PI
DE NOVO DNA METHYLATION IN BLADDER CANCER$304,101
R01 · FY2006 · CA · contact PI
Senior Leadership$287,324
P30 · FY2006 · CA · contact PI
Program Leaders of Research Programs$286,564
P30 · FY2006 · CA · contact PI
TRAINING PROGRAM IN VIRAL AND CHEMICAL CARCINOGENESIS$285,563
T32 · FY2006 · CA · contact PI
Developmental Funds$284,173
P30 · FY2006 · CA · contact PI
Protocol Specific Research$78,020
P30 · FY2006 · CA · contact PI
DE NOVO DNA METHYLATION IN BLADDER CANCER$48,233
R01 · FY2006 · CA · contact PI
Program Planning and Evaluation$32,476
P30 · FY2006 · CA · contact PI
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$6,024,874
P30 · FY2005 · CA
MOLECULAR MECHANISMS OF HUMAN BLADDER CARCINOGENESIS$1,399,377
P01 · FY2005 · CA
MECHANISMS OF DE NOVO METHYLATION IN CANCER$426,730
R01 · FY2005 · CA
DE NOVO DNA METHYLATION IN BLADDER CANCER$310,781
R01 · FY2005 · CA
TRAINING PROGRAM IN VIRAL AND CHEMICAL CARCINOGENESIS$223,250
T32 · FY2005 · CA
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$80,503
P30 · FY2005 · CA
DE NOVO DNA METHYLATION IN BLADDER CANCER$30,079
R01 · FY2005 · CA
DE NOVO DNA METHYLATION IN BLADDER CANCER$30,079
R01 · FY2005 · CA
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$5,945,832
P30 · FY2004 · CA
MOLECULAR MECHANISMS OF HUMAN BLADDER CARCINOGENESIS$1,365,689
P01 · FY2004 · CA
MECHANISMS OF DE NOVO METHYLATION IN CANCER$415,191
R01 · FY2004 · CA
DE NOVO DNA METHYLATION IN BLADDER CANCER$302,193
R01 · FY2004 · CA
TRAINING PROGRAM IN VIRAL AND CHEMICAL CARCINOGENESIS$230,722
T32 · FY2004 · CA
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$168,753
P30 · FY2004 · CA
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$80,400
P30 · FY2004 · CA
DE NOVO DNA METHYLATION IN BLADDER CANCER$42,648
R01 · FY2004 · CA
DE NOVO DNA METHYLATION IN BLADDER CANCER$42,648
R01 · FY2004 · CA
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$5,783,714
P30 · FY2003 · CA
MOLECULAR MECHANISMS OF HUMAN BLADDER CARCINOGENESIS$1,332,014
P01 · FY2003 · CA
MECHANISMS OF DE NOVO METHYLATION IN CANCER$384,436
R01 · FY2003 · CA
DE NOVO DNA METHYLATION IN BLADDER CANCER$295,254
R01 · FY2003 · CA
TRAINING PROGRAM IN VIRAL AND CHEMICAL CARCINOGENESIS$195,732
T32 · FY2003 · CA
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$168,829
P30 · FY2003 · CA
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$80,046
P30 · FY2003 · CA
DE NOVO DNA METHYLATION IN BLADDER CANCER$31,931
R01 · FY2003 · CA
DE NOVO DNA METHYLATION IN BLADDER CANCER$31,931
R01 · FY2003 · CA
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$5,736,555
P30 · FY2002 · CA
MOLECULAR MECHANISMS OF HUMAN BLADDER CARCINOGENESIS$1,301,884
P01 · FY2002 · CA
MECHANISMS OF DE NOVO METHYLATION IN CANCER$374,449
R01 · FY2002 · CA
DE NOVO DNA METHYLATION IN BLADDER CANCER$288,516
R01 · FY2002 · CA
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$75,884
P30 · FY2002 · CA
Silencing of Apoptotic Pathways in TCC by DNA Methylation$0
P01 · FY2002 · CA
CORE--DEVELOPMENT FUNDS$0
P30 · FY2002 · CA
CORE--DEVELOPMENT FUNDS$0
P30 · FY2002 · CA
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT$5,639,156
P30 · FY2001 · CA
MECHANISMS OF DE NOVO METHYLATION IN CANCER$364,751
R01 · FY2001 · CA